Ascend Wellness (AAWH) Q3 2025 earnings summary

Executive summary

• Q3 2025 saw continued industry headwinds, including regulatory uncertainty, price compression, and intensified competition, but also strong consumer demand trends favoring cannabis over alcohol.

• Net revenue for Q3 2025 was $124.7 million, a 2% sequential decline, with retail revenue down 3.1% and wholesale revenue up 0.3%.

• Adjusted EBITDA reached $31.1 million, an 8.9% increase quarter-over-quarter, with a margin of 24.9%.

• Strategic focus remained on profitability, sustainability, and market densification, with over $30 million in annual expenses eliminated and seven new stores added year-to-date, expanding the footprint to 46 locations.

• Digital and loyalty initiatives, including a new e-commerce platform and revamped loyalty program, drove customer engagement and operational efficiency.

Financial highlights

• Net revenue for Q3 was $124.7 million, down 2% sequentially; retail sales were $83.8 million, down 3.1% from Q2; wholesale revenue was $41.0 million, up 0.3%.

• Adjusted gross profit rose 4.6% quarter-over-quarter to $57.8 million, with adjusted gross margin up 300 basis points to 46.4%.

• Adjusted EBITDA increased 8.9% to $31.1 million, with margin expanding to 24.9%.

• Gross profit (GAAP) was $43.6 million (35.0% margin), up from $41.4 million (32.5%) in Q2 2025.

• Ended Q3 with $87.3 million in cash; net debt was $281.8 million.

Outlook and guidance

• Q4 revenue expected to be slightly down sequentially due to holiday promotions and ongoing headwinds, but adjusted EBITDA margin is projected to exceed 23%.

• Retail development pipeline includes 13 additional stores, aiming for 60 locations within 12 months, subject to regulatory approvals.

• Continued focus on cost control, operational efficiency, and margin improvement.

• Ongoing investments in product innovation and customer engagement platforms to drive long-term loyalty and margin expansion.